APTALIS 15 (Zenpep pancrelipase (15,000 units lipase, 51,000 units protease, 82,000 units amylase))

Generic Name: pancrelipase

Pill imprint APTALIS 15 has been identified as Zenpep pancrelipase (15,000 units lipase, 51,000 units protease, 82,000 units amylase).

Zenpep is used in the treatment of chronic pancreatitis; pancreatic exocrine dysfunction; cystic fibrosis and belongs to the drug class digestive enzymes. Risk cannot be ruled out during pregnancy. Zenpep pancrelipase (15,000 units lipase, 51,000 units protease, 82,000 units amylase) is not a controlled substance under the Controlled Substance Act (CSA).

Zenpep

Generic Name:

pancrelipase

Imprint:

APTALIS 15

Strength:

pancrelipase (15,000 units lipase, 51,000 units protease, 82,000 units amylase)

Color:

Red & White

Shape:

Capsule-shape

Availability:

Rx and/or OTC

Drug Class:

Digestive enzymes

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Aptalis Pharma US, Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.